Renal Safety of Telminuvo, a Single Pill Combination of Telmisartan and S-amlodipine, in Korean Hypertensive Patients: A Multicenter, Retrospective Cohort Study
This cohort study demonstrates that Telminuvo effectively reduces blood pressure without compromising kidney function. Furthermore, the findings provide additional insights into drug-related adverse events, which will be valuable for clinicians in the real-world prescribing of Telminuvo.
Authors
- Min‐Su Hyon (ORCID: https://orcid.org/0000-0002-8202-7535)
- Sung Uk Kwon (ORCID: https://orcid.org/0000-0003-3435-3819)
- Seung Seok Han (ORCID: https://orcid.org/0000-0003-0137-5261)
- Hongran Moon (ORCID: https://orcid.org/0000-0002-0076-9413)
- Sohyun Bae (ORCID: https://orcid.org/0000-0002-0206-7108)
- Dong Hwan Yun (ORCID: https://orcid.org/0000-0003-1800-319X)
- Hyung‐Kwan Kim (ORCID: https://orcid.org/0000-0001-7950-2131)
Institutions
- Seoul National University (KR)
- Soonchunhyang University Hospital Seoul (KR)
- Seoul National University Hospital (KR)
- Inje University Ilsan Paik Hospital (KR)
Publication Details
- Journal
- Electrolytes & Blood Pressure
- Published
- 2025-01-01
- DOI
- https://doi.org/10.5049/ebp.2025.23.e1
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00